Vitiligo
Dermatology, Venereology & Leprosy · Topic 2
Source: NMC CBME Curriculum 2024 · Volume II · Dermatology, Venereology & Leprosy · Topic 2 · combined PDF page 356
Practice questions
- Which pathogenic description best matches vitiligo in the supplied current guideline?
- A patient has acquired depigmented macules. Which underlying tissue change is most consistent with the supplied description of vitiligo?
- Which pair of clinical categories is explicitly addressed in the European Dermatology Forum consensus on vitiligo treatment?
- Which statement is supported by the supplied guideline descriptions of vitiligo diagnosis?
- A patient with vitiligo reports substantial distress because lesions involve cosmetically sensitive areas. Which management principle is most consistent with the supplied guidelines?
- According to the older systematic review summarized in the supplied literature, which treatment was identified as among the most effective and safest for localized vitiligo?
- In the older systematic review summarized in the supplied literature, which modality was identified as among the most effective and safest for generalized vitiligo?
- A patient with widespread vitiligo is considering PUVA. Which comparison with UVB is supported by the supplied PUVA guideline?
- Which mechanism is described as a proposed way PUVA may promote repigmentation in vitiligo?
- A patient has limited facial vitiligo and asks about a topical JAK inhibitor. Which option is supported as a first-line choice in the supplied 2026 meta-analysis?
- In the supplied meta-analysis, what was the primary outcome used to evaluate JAK inhibitors in the included randomized trials?
- The pooled relative risk for F-VASI75 with JAK inhibitors versus placebo was 4.59. Which interpretation is most appropriate?
- A clinician is discussing oral JAK inhibitors for vitiligo. Which counseling point best reflects the supplied meta-analysis?
- What did the supplied 2026 meta-analysis report about serious adverse events with JAK inhibitors compared with control groups?
- A patient has patches that have not responded to medical treatment and asks whether surgery is appropriate. Which additional feature best fits the supplied surgical guideline's indication?
- For the purpose of considering vitiligo surgery, what period without disease progression does the supplied IADVL surgical guideline suggest as a definition of stability?
- A patient is being considered for surgery, but disease stability is uncertain. Which option is specifically mentioned in the supplied surgical guideline as a way to assess stability?
- Which counseling statement is most appropriate before vitiligo surgery, based on the supplied surgical guideline?
- Which postoperative measure is specifically emphasized in the supplied vitiligo surgery guideline as important for satisfactory results?
- A patient with stable vitiligo is being considered for a surgical approach. Which group of procedures is explicitly included among the techniques assessed in the supplied guidelines?
- According to the systematic review summarized in the supplied literature, which group of patients could be successfully treated with most autologous transplantation methods?
- For vitiligo universalis, which comparison between depigmentation approaches is reported in the supplied systematic review summary?
- A patient with vitiligo asks whether treatment is obligatory. Which option is included among the management approaches considered by the supplied UK guideline?
- Which statement best describes the role of camouflage and sunscreen in the supplied vitiligo guideline?
- A clinician is designing a vitiligo treatment plan using the principles described in the supplied Japanese guideline. Which goal is most consistent with that guideline?
- A question asks whether current evidence supports using PUVA in widespread vitiligo, while recognizing other phototherapy options. Which answer is best supported?
- Which statement about the certainty and scope of the supplied JAK inhibitor meta-analysis is most accurate?
- A patient is considering vitiligo surgery after medical treatment has not helped. Which statement best reflects the supplied guideline's approach to stability?
- Which feature of vitiligo is specifically linked to quality-of-life impact in the supplied Japanese guideline summary?